Good news: Another study showing that fasting can help cancer patients. A 16 hour fast enh

Partially SupportedThree cycles of a fasting regimen significantly enhanced anti-PD1 efficacy in B16F10 and MC38 tumor mouse models.

Well SupportedFasting can increase a patient's chances of surviving cancer.

Partially SupportedFasting can cause cancer cells to release isoleucine, leading to increased isoleucine processing and intracellular acetyl-CoA in the tumor microenvironment.

Partially SupportedA 16-hour fast can enhance T cell cancer-killing activity and synergize with immunotherapy to reduce tumor size.

Partially Supported